• DOI:10.1016/j.toxlet.2012.04.019
Corpus ID: 205444257

Research chemicals marketed as legal highs: the case of pipradrol derivatives.

@article{Coppola2012ResearchCM,
  title={Research chemicals marketed as legal highs: the case of pipradrol derivatives.},
  author={M. Coppola and R. Mondola},
  journal={Toxicology letters},
  year={2012},
  volume={212 1},
  pages={
          57-60
        }
}

M. Coppola, R. Mondola

Published 2012

Medicine

Toxicology letters

Between 1997 and 2011, more than 200 new substances were notified through the early-warning system, with the record number of 49 novel molecules reported in 2011. The pattern of acute toxicity associated with the consumption of these new substances is generally similar to that seen with traditional drugs of abuse. Recently, a new class of synthetic stimulants closely related to pyrrolidine and piperidine compounds and known as pipradrol derivatives appeared in the recreational drug market… CONTINUE READING

View on PubMed

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed